The concept of metabolically ‘benign’ obesity with preservation of insulin sensitivity is established, with some studies identifying a favorable cardiometabolic profile with reduced incidence of type 2 diabetes compared to unhealthy obesity (43, 44). This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.